Article
Quantitation of Promoter Methylation of Multiple Genes in Urine DNA and Bladder Cancer Detection
18 Jul 2006
Abstract excerpt
BACKGROUND: The noninvasive identification of bladder tumors may improve disease control and prevent disease progression. Aberrant promoter methylation (i.e., hypermethylation) is a major mechanism for silencing tumor suppressor genes and other cancer-associated genes in many human cancers, including bladder cancer. METHODS: A quantitative fluorogenic real-time polymerase chain reaction (PCR) assay was used to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
